Overview
Background
Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath
- Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
- Full Professor, University of Queensland Faculty of Medicine
- Visiting Medical Officer, Greenslopes Private Hospital
Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.
She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.
She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.
Qualifications
MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath
Current UQ Appointments
Academic Title-Professor
Non-UQ Appointments
2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology
2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital
2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital
June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane
1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital
1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board
Research Interests
- Granular tumour necrosis
- Diagnosis of limited adenocarcinoma on prostate needle biopsy
- Ductal adenocarcinoma of prostate
- Mucinous adenocarcinoma of prostate
- Radical prostatectomy handling and reporting
- Micropapillary urothelial cancer
- Mimics of bladder cancer
Awards and other Esteem Indicators
2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works
2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology
2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of
Article of the Year by the Royal College of Pathologists of Australasia.
2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia
For distinguished service to the discipline of Urological Pathology
Keywords
Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Fields of research
Research impacts
She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.
Works
Search Professor Hemamali Samaratunga’s works on UQ eSpace
2017
Journal Article
Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study
Kristiansen, Anna, Drevin, Linda, Delahunt, Brett, Samaratunga, Hemamali, Robinson, David, Franck Lissbrant, Ingela, Stattin, Pär and Egevad, Lars (2017). Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study. Pathology, 49 (7), 715-720. doi: 10.1016/j.pathol.2017.08.008
2017
Journal Article
The decline of medical publishing: the rise of the pseudo-journal
Delahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2017). The decline of medical publishing: the rise of the pseudo-journal. Pathology, 49 (7), 673-674. doi: 10.1016/j.pathol.2017.08.001
2017
Journal Article
Pathology Imagebase-a reference image database for standardization of pathology
Egevad, Lars, Cheville, John, Evans, Andrew J., Hornblad, Jonas, Kench, James G., Kristiansen, Glen, Leite, Katia R. M., Magi-Galluzzi, Cristina, Pan, Chin-Chen, Samaratunga, Hemamali, Srigley, John R., True, Lawrence, Zhou, Ming, Clements, Mark and Delahunt, Brett (2017). Pathology Imagebase-a reference image database for standardization of pathology. Histopathology, 71 (5), 677-685. doi: 10.1111/his.13313
2017
Journal Article
Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells
Kryza, Thomas, Silva, Lakmali M., Bock, Nathalie, Fuhrman-Luck, Ruth, Stephens, Carson, Gao, Jin, Samaratunga, Hema, Lawrence, Mitchell, Hooper, John D., Dong, Ying, Risbridger, Gail and Clements, Judith A. (2017). Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells. Molecular Oncology, 11 (10), 1307-1329. doi: 10.1002/1878-0261.12075
2017
Journal Article
Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases
Samaratunga, Hemamali, Delahunt, Brett, Srigley, John R., Yaxley, John, Johannsen, Shulammite, Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, Patterson, Imogen, Nacey, John N. and Egevad, Lars (2017). Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases. Histopathology, 71 (4), 641-647. doi: 10.1111/his.13278
2017
Journal Article
Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading
Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Srigley, John R, Coughlin, Geoffrey, Dunglinson, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon, Yaxley, John and Samaratunga, Hemamali (2017). Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading. Histopathology, 71 (6), 918-925. doi: 10.1111/his.13311
2017
Journal Article
Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years
Yaxley, John W., Lah, Kevin, Yaxley, Julian P., Gardiner, Robert A., Samaratunga, Hema and MacKean, James (2017). Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years. BJU International, 120 (1), 56-60. doi: 10.1111/bju.13659
2017
Conference Publication
PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases
Scott, Susan E., Gianduzzo, Troy, Coughlin, Geoff, Kua, Boon, Parkinson, Rob, Samaratunga, Hemamali and Yaxley, John (2017). PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases. ANZUP Annual Scientific Meeting - The Art & Science of Best Practice, Melbourne, VIC Australia, 16–18 July 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2017
Journal Article
UICC drops the ball in the 8th edition TNM staging of urological cancers
Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Varma, Murali, Verrill, Clare, Cheville, John, Kristiansen, Glen, Corbishley, Catherine and Berney, Daniel M. (2017). UICC drops the ball in the 8th edition TNM staging of urological cancers. Histopathology, 71 (1), 5-11. doi: 10.1111/his.13200
2017
Journal Article
Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited
Siriwardana, Amila, Thompson, James, van Leeuwen, Pim J., Doig, Shaela, Kalsbeek, Anton, Emmett, Louise, Delprado, Warick, Wong, David, Samaratunga, Hemamali, Haynes, Anne-Maree, Coughlin, Geoff and Stricker, Phillip (2017). Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. BJU International, 120 (5), 673-681. doi: 10.1111/bju.13919
2017
Conference Publication
Diagnostic potential of PSMA PET in advanced renal cell carcinoma
Nicholson, C., Joshi, A., Rhee, H., Tham, M., Thomas, P., Blazak, J., Samaratunga, H., Ng, K. L., Globe, G., Vela, I. and Wood, S. (2017). Diagnostic potential of PSMA PET in advanced renal cell carcinoma. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750
2017
Journal Article
Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam
Egevad, Lars, Samaratunga, Hemamali and Delahunt, Brett (2017). Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam. International Journal of Urology, 24 (4), 286-287. doi: 10.1111/iju.13305
2017
Journal Article
Prostate cancer grading: a decade after the 2005 modified Gleason grading system
Delahunt, Brett, Grignon, David J., Samaratunga, Hemamali, Srigley, John R., Leite, Katia R. M., Kristiansen, Glen, Evans, Andrew J., Kench, James G. and Egevad, Lars (2017). Prostate cancer grading: a decade after the 2005 modified Gleason grading system. Archives of Pathology and Laboratory Medicine, 141 (2), 182-183. doi: 10.5858/arpa.2016-0300-LE
2017
Conference Publication
Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells
Nicholson, C., Rhee, H., Ng, K. L., Tse, B. W., Yeh, M-C, Russell, P., Nelson, C., Thomas, P., Samaratunga, H., Vela, I., Gobe, G. and Wood, S. (2017). Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750
2016
Journal Article
Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al
Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al. International Journal of Radiation Oncology - Biology - Physics, 96 (5), 1126-1127. doi: 10.1016/j.ijrobp.2016.08.029
2016
Journal Article
New Gleason grading system: statement from the editors of 6 journals
Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). New Gleason grading system: statement from the editors of 6 journals. Urologic Oncology: Seminars and Original Investigations, 34 (11), 479-480. doi: 10.1016/j.urolonc.2016.07.003
2016
Journal Article
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease
Rhee, Handoo, Ng, Keng Lim, Tse, Brian Wan-Chi, Yeh, Mei-Chun, Russell, Pamela J., Nelson, Colleen, Thomas, Paul, Samaratunga, Hemamali, Vela, Ian, Gobe, Glenda and Wood, Simon (2016). Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. Pathology, 48 (6), 613-616. doi: 10.1016/j.pathol.2016.05.011
2016
Journal Article
One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading
Srigley, John R., Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Yaxley, John and Evans, Andrew J. (2016). One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading. Canadian Urological Association Journal, 10 (9-10), 339-341. doi: 10.5489/cuaj.4146
2016
Journal Article
Reply by the authors
Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Reply by the authors. Urology, 96, 179-180. doi: 10.1016/j.urology.2016.07.006
2016
Journal Article
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna, Lavin, Martin F. and Gardiner, Robert A. (2016). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet, 388 (10049), 1057-1066. doi: 10.1016/S0140-6736(16)30592-X
Funding
Past funding
Supervision
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Completed supervision
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Associate Professor David Vesey, Honorary Professor Li Li
-
2019
Doctor Philosophy
Cellular and molecular mechanisms of pancreatitis in atrophy and regeneration
Associate Advisor
Media
Enquiries
For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team: